Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats
about
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepModern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targetsLAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosisSmall RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.The use of marine-derived bioactive compounds as potential hepatoprotective agentsBile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasisTargeted treatments for cirrhosis.Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury.Understanding the mechanism of hepatic fibrosis and potential therapeutic approachesL(59) TGF-β LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice.Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis.Emerging therapies for liver fibrosis.Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy.Matrix metalloproteinase gene delivery for liver fibrosisGene modulation for treating liver fibrosisNew gene therapy strategies for hepatic fibrosisSaikosaponin a and saikosaponin d inhibit proliferation and migratory activity of rat HSC-T6 cells.Induction of experimental obstructive cholestasis in mice.CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes.Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease.Effects of TGF-beta1 Ribbon Antisense on CCl(4)-induced Liver Fibrosis.Global identification and analysis of isozyme-specific possible substrates crosslinked by transglutaminases using substrate peptides in mouse liver fibrosisDevelopment and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosisHepatic apoptosis can modulate liver fibrosis through TIMP1 pathway.Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis.Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis.
P2860
Q26771518-089DAEEB-0F88-4A6B-82BE-172845CFF7F3Q28303698-DD826873-A154-44AA-89E6-F0F9E518F311Q33662935-F036EB2F-EBE3-4487-9803-4A9BDBFF1372Q34405044-D4C0CF56-3859-4346-98F4-C20D719CD6B5Q35010511-19D95284-7741-42E6-9F2D-45D7C7DD4EAAQ35080141-26E8BB8B-9058-4E0E-92AA-E368DC6E06CEQ35162240-1A1C9673-B29F-4835-9720-829430C68E5CQ35911123-41ECEABE-AD72-4F34-8184-53DF3C336203Q35922580-E9682C2D-51A4-4B27-A754-37464A643E7CQ36020916-DACF6D6D-2EFD-4CD7-BEA9-DA8602AD4CD5Q36061706-923C97B8-52BE-4138-8096-35A79556B324Q36371664-41A6012A-DC26-4842-87DC-8DB6D1172E6BQ36478124-188BAF78-F49F-4DFD-83F0-BB309BFCA077Q36779299-15DF2825-ABE6-4E96-9616-129ABEFB2952Q36852793-235248EC-F93E-4D52-8DC7-B3693E436EB5Q36921638-03B325F2-335D-494D-B035-59858136F5D9Q38410812-D873258E-3E2B-444B-8D1F-8BDCB6B6262CQ39094742-FC9F9AC5-4DCF-474C-8EF6-74434BB0E6F5Q39191568-9C279513-49AD-4243-B895-A671B2F14D8AQ39508427-677ED25D-26EF-4EC6-B11B-A0C107420727Q40158072-44F3B192-817D-4B38-8AE4-4E825F3D68BCQ40456120-FDADDBB9-24C9-42F4-97C4-1CD7C6898114Q41043694-DB9FA9A6-652C-4739-A859-23B14C635B73Q41846376-2DFB9A0F-ACA9-468C-9CDE-7D4FBDC7A661Q42241587-F6D63107-3D7F-4A5A-8015-E27592E07AD5Q42733686-57802641-F484-4E1A-9347-9880F75B8DC9Q44213281-0113A604-2A53-4CB4-9DBD-600732E23D86Q47785420-AAC27A69-2F3D-43C5-9EF7-42D1DC58B20EQ52668406-59D9FD94-20A0-47CC-B802-F54E71A08B1C
P2860
Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Adenoviral expression of a tra ...... osis in bile-duct ligated rats
@ast
Adenoviral expression of a tra ...... osis in bile-duct ligated rats
@en
Adenoviral expression of a tra ...... osis in bile-duct ligated rats
@nl
type
label
Adenoviral expression of a tra ...... osis in bile-duct ligated rats
@ast
Adenoviral expression of a tra ...... osis in bile-duct ligated rats
@en
Adenoviral expression of a tra ...... osis in bile-duct ligated rats
@nl
prefLabel
Adenoviral expression of a tra ...... osis in bile-duct ligated rats
@ast
Adenoviral expression of a tra ...... osis in bile-duct ligated rats
@en
Adenoviral expression of a tra ...... osis in bile-duct ligated rats
@nl
P2093
P2860
P356
P1433
P1476
Adenoviral expression of a tra ...... osis in bile-duct ligated rats
@en
P2093
Axel M Gressner
Ingo Theuerkauf
Jens Treptau
Monica Arias
Nora Janoschek
Reinhard Buettner
Sibille Sauer-Lehnen
P2860
P2888
P356
10.1186/1471-230X-3-29
P407
P577
2003-10-18T00:00:00Z
P6179
1050849228